The vaccine, Nexvan2, is being tested worldwide. The first test was in 2011 and found the vaccine to be safe. In 2017, $40 million in funding was received by the company developing the vaccine, ImmusanT. The funding will allow additional research, including a second round of testing that is set to include 150 patients from the United States, Australia, and New Zealand.
“Through this study we anticipate making new insights that will further our ability to demonstrate specific suppression of the immune response to gluten epitopes and associated effects of celiac disease,” Dr. Ken Truitt, ImmusanT chief medical officer, told BeyondCeliac.org.
Follow the progress of this life-changing vaccine here.
11% OFF Under the Nile Baby Long Sleeve Side Snap Kimono Sage Stripe$32.00 $36.00
Under the Nile Organic Training Pants - 2-4 Years$13.00
40% OFF Under the Nile Hooded Towel and Wash Mitt Set$28.20 $47.00
11% OFF Under the Nile Swaddle Blanket$42.00 $47.00
5% OFF Under the Nile Organic Fruit Tote$40.00 $42.00
16% OFF Under the Nile Muslin Bunting$32.00 $38.00
- Organic Baby